Over $3,000 Paid Clinical Trials
440 studies
Extended inpatient Phase 1 studies with longer residential stays or multiple periods may compensate $3,000 or more.
Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.
Showing 61–80 of 440 studies
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers
Healthy Volunteers
Hunan Kelun Pharmaceutical Co., Ltd.76 enrolled1 locationNCT07474545
Recruiting
Phase 1
First-in-Human Single and Multiple Dose of KLA578-1 for Injection
Healthy Volunteers
Hunan Kelun Pharmaceutical Co., Ltd.48 enrolled1 locationNCT07143318
Recruiting
Phase 1
Single-dose,First-in-human of KLA478
Healthy Volunteers
Hunan Kelun Pharmaceutical Co., Ltd.40 enrolled1 locationNCT07240675
Recruiting
Phase 1
A Phase I Study of KLA318-2 Nanocrystal Injection
Healthy Participants
Hunan Kelun Pharmaceutical Co., Ltd.48 enrolled1 locationNCT07171034
Recruiting
Phase 1
Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
Healthy VolunteerPharmacokinetics
Ensysce Biosciences54 enrolled1 locationNCT06500793
Recruiting
Phase 1
PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects
Healthy Volunteers
Intra-Cellular Therapies, Inc.42 enrolled1 locationNCT06299410
Recruiting
Phase 1
A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646)
Healthy
Merck Sharp & Dohme LLC16 enrolled1 locationNCT07532304
Recruiting
Phase 1
A Study to Assess the Absolute Bioavailability of Empasiprubart SC Administered With an Autoinjector and the Pharmacokinetic Noninferiority of Empasiprubart SC Versus Intravenous (IV) in Healthy Adult Participants
Healthy Volunteers
argenx130 enrolled1 locationNCT07612020
Recruiting
Phase 1Phase 2
Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions
Healthy VolunteerVancomycinHypersensitivity Reactions
Johns Hopkins University25 enrolled1 locationNCT07605806
Recruiting
Phase 1
A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
HealthyIdiopathic Inflammatory MyopathiesSystemic Sclerosis+1 more
Xencor, Inc.60 enrolled1 locationNCT07284797
Recruiting
Phase 1
A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and Women
Healthy
Boehringer Ingelheim100 enrolled1 locationNCT06916702
Recruiting
Phase 1
A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting Conditions
Healthy Adults
Pfizer30 enrolled1 locationNCT07587697
Recruiting
Phase 1
Relative Bioavailability and Impact of Rabeprazole for PF-07799933, Food-Effect for PF-07799933 and PF-07799544
Healthy
Pfizer16 enrolled1 locationNCT07563894
Recruiting
Phase 1Phase 2
Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Androgenetic alopecia (AGA)Healthy Volunteers - Male and Female
Absci Pty Ltd.227 enrolled4 locationsNCT07317544
Recruiting
Phase 1Phase 2
Study of TGM-312-SC01 in Healthy Participants and Adults With MASH
Healthy ParticipantsMASH - Metabolic Dysfunction-Associated Steatohepatitis
Tangram Therapeutics Plc99 enrolled1 locationNCT07427680
Recruiting
Phase 1
Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
healthy adult participantsDiabetic Kidney Disease
Mediar Therapeutics88 enrolled1 locationNCT07473323
Recruiting
Phase 1
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LG-0317 in Healthy Participants
Healthy Volunteers
LinGang Laboratory100 enrolled1 locationNCT07522970
Recruiting
Phase 1
Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions
Healthy Adult
Sichuan Huiyu Pharmaceutical Co., Ltd70 enrolled1 locationNCT07606105
Recruiting
Phase 1
A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function
HealthyLiver Dysfunction
Eli Lilly and Company33 enrolled4 locationsNCT06916078
Recruiting
Phase 1
A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects
Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.72 enrolled1 locationNCT07594847